Close menu

July 27th, 2022 | 10:37 CEST

Lufthansa, Kleos Space, Palantir - Shares about to take off

  • Space
  • travel
  • Investments
Photo credits:

Currently, most investors are on edge. The uncertainties on a geopolitical and economic level are increasing - a never-ending conflict in Ukraine, fears of an impending global recession and inflation data at record levels. In addition, the next wave of the Corona pandemic is supposedly just around the corner. Nevertheless, after the sharp correction of the past months, there are interesting entry opportunities at discounted levels.

time to read: 4 minutes | Author: Stefan Feulner

Table of contents:

    Kleos Space - Delay offers opportunities

    The Luxembourg-based company Kleos Space is in the right place at the right time with the right technology. For it is precisely in times of conflict and uncertainty in geopolitics that the Company, founded in Australia, is in demand. It operates space-based signal and geodata surveillance, which is just as important for the defense sector as it is for security and surveillance.

    The Data-as-a-Service company launches satellite clusters, each consisting of four units, into space to scan the Earth for radio frequency signals for geolocation. The Scouting Mission satellites are launched at an inclination of 37 degrees and collect data over key areas on the high seas such as the Strait of Hormuz, the South China Sea, East and West Africa, the Southern Sea of Japan and the northern coast of Australia.

    The data obtained is then processed using in-house algorithms, packaged and sold to government and commercial analysis and intelligence services on a subscription model. So far, three satellite clusters have been launched into space. The fourth has been delayed, which put the share price under strong pressure in the short term. However, the Company has confirmed that the fourth satellite cluster, Observer, will launch with SpaceX's next Transporter 6 mission in October 2022. In the process, the satellites will expand Kleos Space's data collection capacity by up to 119 million sq km per day and increase the average daily review rate to about five times per day.

    The innovative company plans to develop and deploy 20 clusters in the medium term. In order to fund growth, a four-year, USD 10 million secured loan has been raised from PURE Asset Management.

    "Kleos is in a period of rapid growth, responding to market needs for greater situational awareness. Increasing global risks and conflicts have driven the demand for intelligence, surveillance and reconnaissance data. With each new group of satellites we operate, we increase our data collection capacity and revenue generation opportunities," said Andy Bower, CEO of Kleos Space. After the setback, the stock, which is also traded in Germany, is extremely attractive, especially in view of further uncertain times.

    Lufthansa - The vacation must wait

    It would have been so nice - bellowing the currently most famous party hit, "Layla", which is frowned upon at German folk festivals, accompanied by buckets of sangria. But the reality, not only for the people celebrating life, looks different. The reason is the Verdi warning strike, which paralyzed almost the entire program at the German hubs of Frankfurt and Munich on Wednesday. There will be flight cancellations this Tuesday, Thursday, and Friday, the Company announced in Frankfurt. More than 1,000 flights are said to be cancelled, with more than 134,000 passengers affected.

    Verdi's appeal encouraged ground employees to stage nationwide work stoppages to build up pressure in the ongoing salary negotiations. As a result, Lufthansa's Chief Human Resources Officer, Michael Niggemann, expressed his incomprehension and criticism: "The early escalation after only two days of negotiations in what has so far been a constructive round of wage negotiations is causing enormous damage. It is particularly affecting our passengers during the peak travel season. And it puts an additional heavy burden on our employees in an already difficult phase of air traffic."

    Shareholders of the Crane share are likely to be in a similar mood to the affected travelers. After the paper was still in positive terrain at the beginning of the trading day, it turned negative by around 2% to EUR 5.91. Thus, the chart picture clouds again, and a test of the annual low at EUR 5.24 moves closer, especially since the relative strength index and the MACD deliver sell signals daily again. Thus, the same credo applies to shareholders as to the plagued holidaymakers: "Stay on the ground!"

    Palantir - Optimistic analyst opinions

    In contrast to the German airline, there is no strike at the data analysis company from Denver, Colorado. On the contrary, since bottoming out at USD 6.44, Palantir shares have gained about 50% since mid-May to USD 9.68 despite a weak tech market. After failing at the resistance zone at USD 10.38, the value is currently running sideways. On the upside, breaking above the USD 10.76 mark would generate a buy signal. On the downside, the upward trend formed since May at currently USD 9.04 should not be sustainably undercut.

    Positive analyst opinions gave the share a tailwind. Investment house Raymond James started coverage of the growth company. Analyst Brian Gesuale rated the stock a "strong buy" with a USD 20 price target, pointing out that the stock has fallen 75% since its early 2021 peak, making the risk premium "compelling." "The Company nearly doubled its revenue from 2018 to 2020, passing the billion-dollar mark, and we believe the Company could double again, flirting with the USD 2 billion revenue mark in 2022," Gesuale wrote.

    Postponements and delays were not limited to Lufthansa; Kleos Space's fourth satellite cluster was also pushed back. As a result, the stock plummeted and should currently be at an interesting entry level. Palantir received a "strong buy" from analysts with a price potential of more than 100%.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by André Will-Laudien on September 28th, 2023 | 08:05 CEST

    Attention: Extended correction - Buy the right stocks now! Bayer, Viva Gold, TUI, and BASF are on the list!

    • Mining
    • Gold
    • Pharma
    • chemicals
    • travel

    Higher inflation and rising interest rates - this connection should be clear to investors. The interest rate level in Germany has moved from negative territory to 2.77% in the 10-year range, but stocks continued to rise cheerfully. The party led to all-time highs of 16,528 points in July, but the fundamental situation of the companies deteriorated in parallel. Only after repeated warnings from the US Federal Reserve did the explosive NASDAQ also enter a correction. And it continues. Yesterday, the CEO of US investment bank JPMorgan, Dimon, warned that the world may not be prepared for 7% capital market interest rates. He and Dr. Jens Erhardt, the CEO of the asset management company DJE, warn of stronger setbacks on the stock markets. Some stocks have already undergone a strong correction. Here is a brief overview.


    Commented by André Will-Laudien on September 26th, 2023 | 07:45 CEST

    Artificial Intelligence in Sellout! Nvidia, Defense Metals, ARM Holdings - Nothing works without rare earths!

    • Mining
    • RareEarths
    • AI
    • chips
    • Investments

    After long bull market movements, the stock market usually tends to rotate sectors, or the market enters a general consolidation. In the former case, investors can profit by reallocating their assets while exploring new investment opportunities. In the latter case, all stocks come down, and the capital market generally suffers from a change in sentiment and corrects recently exaggerated valuations. In the case of the new megatrend of Artificial Intelligence (AI), the stock market seems to sense a great need for correction. As if by magic, the blockbuster stock Nvidia rose by 250% in just 9 months. However, it has already retraced nearly 20% from its peak. Where do the opportunities lie for investors?